Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Quoin Pharmaceuticals, Ltd. - American Depositary Shares
(NQ:
QNRX
)
6.100
-0.270 (-4.24%)
Streaming Delayed Price
Updated: 12:11 PM EDT, May 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Quoin Pharmaceuticals, Ltd. - American Depositary Shares
Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome
January 20, 2026
If granted, QRX003 could be approved for sale and reimbursement in Saudi Arabia as a treatment for Netherton Syndrome in 2H 2026
From
Quoin Pharmaceuticals, Ltd.
Via
GlobeNewswire
Money Movers: HIT, SEPN, ALUR, LUCY, PRSO – Biotech, Healthcare, AI & Weight Loss Innovators Lead Momentum Surge – More Stocks Inside
May 14, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies
January 23, 2025
Via
ACCESS Newswire
Asensus Surgical Continues to Spearhead Innovations and Growth in Surgical Robotics
August 17, 2023
From
PCG Digital
Via
ACN Newswire
Asensus Shares First Quarter Results and Future Plans
June 01, 2023
From
PCG Digital
Via
ACN Newswire
REPEAT -- Quoin Pharmaceuticals Announces Additional Positive Clinical Data from Open-Label, Single-Arm Clinical Trial in Netherton Syndrome
October 24, 2023
From
Quoin Pharmaceuticals, Inc.
Via
GlobeNewswire
Quoin Pharmaceuticals' Commitment to Delivering Treatment for Netherton Syndrome Patients and Creating Value for Shareholders
August 09, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
A Pivotal Year Ahead for Quoin Pharmaceuticals
March 01, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Quoin Pharmaceuticals: Strategically Building For Future Success
June 14, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Skinvisible Announces First Invisicare Delivery Technology Product to Receive U.S. FDA Acceptance of Investigational New Drug
June 06, 2022
LAS VEGAS, NV / ACCESSWIRE / June 6, 2022 / Skinvisible, Inc. ("Skinvisible") (OTCQB:SKVI), is pleased to announce that its licensee Quoin Pharmaceuticals, Inc. ("Quoin") (NASDAQ:QNRX), has received...
From
Skinvisible Inc
Via
AccessWire
Quoin Pharmaceuticals Targeting Regulatory Approvals for Lead Candidate for Netherton Syndrome in 2024
March 24, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Changing Lives, Delivering Value: Quoin Pharmaceuticals is Making the Balancing Act Look Easy
February 08, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Quoin Pharmaceuticals Poised for Rapid Commercialization of Promising Pipeline
November 16, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
